Consuming a healthy diet rich in probiotics can play a crucial role in preventing and managing CNS disorders. What else is there to know about psychobiotics and probiotics? Keep an eye out for Part II, where we uncover how psychobiotics impact MS, Parkinson’s, and other disease conditions. Continue reading below to learn about our clinical practice.
Recommended Reading: Functional Medicine Toronto Approach to Leaky Gut and Widespread Inflammation
About our functional medicine approach to wellness
We know that implementing healthy lifestyle decisions can be challenging. But our clinical nutrition and functional medicine strategies can help inspire you to grab hold of your wellness reins!
A customized approach to health care can cater to your condition only. By understanding your individual components, such as your medical history/genetics, current lifestyle factors and environmental factors, we can tailor a distinctive health care plan for your concerns. Our functional medicine treatments may combine a wide variety of tactics to help relieve individual symptoms (i.e. digestive issues, chronic pain/body aches, sleep issues) and promote optimal wellness. Our healthcare providers may offer clinical care from acupuncture, naturopathic medicine, Western medicine, Traditional Chinese Medicine, bio-identical hormone replacement therapy (hormone optimization programs), health detoxification programs, and more.
When you become a patient, you have access to our IV Lounge, where we offer personalized treatment plans with intravenous vitamin therapy. IV drips are blended with the core principles of integrative functional medicine wisdom. When combined with lifestyle modifications and functional medicine therapies, IV therapy could act as adjunct support for your wellness goal.
Functional medicine programs and a healthy lifestyle could promote weight loss and improve gut health. Call (416) 968-6961 to request a health assessment with our functional medicine Toronto providers.
Disclaimer: The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.
Allen AP, Hutch W, Borre YE et al (2016) Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry 6:e939–e939
Anand U, Yiangou Y, Akbar A et al (2018) Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons. PLoS ONE 13:e0198024
Ansari F, Pourjafar H, Tabrizi A, Homayouni A (2020) The effects of probiotics and prebiotics on mental disorders: a review on depression, anxiety, Alzheimer, and autism spectrum disorders. Curr Pharm Biotechnol 21:555–565
Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson’s disease: mechanisms of action. Drug Discov Today 21:802–818
Barichella M, Pacchetti C, Bolliri C et al (2016) Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT. Neurology 87:1274–1280
Bonfili L, Cecarini V, Gogoi O et al (2020) Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer’s disease. Neurobiol Aging 87:35–43. https://doi.org/10.1016/j.neurobiolaging.2019.11.004
Cassani E, Privitera G, Pezzoli G et al (2011) Use of probiotics for the treatment of constipation in Parkinson’s disease patients. Minerva Gastroenterol Dietol 57:117–121
Castelli V, d’Angelo M, Lombardi F et al (2020) Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models. Aging (albany NY) 12:4641
Cloud LJ, Greene JG (2011) Gastrointestinal features of Parkinson’s disease. Curr Neurol Neurosci Rep 11:379–384
Dargahi N, Matsoukas J, Apostolopoulos V (2020) Streptococcus thermophilus ST285 alters pro-inflammatory to anti-inflammatory cytokine secretion against multiple sclerosis peptide in mice. Brain Sci 10:126
Foster JA, Neufeld K-AM (2013) Gut–brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36:305–312
Georgescu D, Ancusa OE, Georgescu LA et al (2016) Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope? Clin Interv Aging 11:1601
Kim DS, Choi H-I, Wang Y et al (2017) A new treatment strategy for Parkinson’s disease through the gut–brain axis: the glucagon-like peptide-1 receptor pathway. Cell Transplant 26:1560–1571
Kim J-S, Sung H-Y (2015) Gastrointestinal autonomic dysfunction in patients with Parkinson’s disease. J Mov Disord 8:76
Kouchaki E, Tamtaji OR, Salami M et al (2017) Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin Nutr 36:1245–1249
Lyte M, Li W, Opitz N et al (2006) Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 89:350–357
Mohammadi AA, Jazayeri S, Khosravi-Darani K et al (2016) The effects of probiotics on mental health and hypothalamic–pituitary–adrenal axis: a randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr Neurosci 19:387–395
Morshedi M, Hashemi R, Moazzen S et al (2019) Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review. J Neuroinflammation 16:1–11
Oroojzadeh, P., Bostanabad, S.Y. & Lotfi, H. Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders. J Mol Neurosci 72, 1952–1964 (2022). https://doi.org/10.1007/s12031-022-02053-3
Sarkar A, Lehto SM, Harty S et al (2016) Psychobiotics and the manipulation of bacteria–gut–brain signals. Trends Neurosci 39:763–781
Tiller JWG (2013) Depression and anxiety. Med J Aust 199:S28–S31
Yong SJ, Tong T, Chew J, Lim WL (2020) Antidepressive mechanisms of probiotics and their therapeutic potential. Front Neurosci 13:1361